Bone Marrow TransplantationAnemia, AplasticBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemiaLeukemiaTransplantation ChimeraTissue DonorsGraft SurvivalHistocompatibility TestingKidney TransplantationBusulfanHistocompatibilityBone and BonesAntilymphocyte SerumHematopoietic Stem CellsImmunosuppressive AgentsBone Marrow PurgingTransplantation, IsogeneicCyclophosphamideBone Marrow DiseasesHematopoiesisRecurrenceGraft RejectionTreatment OutcomeImmunosuppressionPancytopeniaCombined Modality TherapyHeart TransplantationStem Cell TransplantationGraft vs Host ReactionLeukemia, Myeloid, AcuteCyclosporineTime FactorsRadiation ChimeraHematologic NeoplasmsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationMice, Inbred C57BLTransplantation ImmunologyMyelodysplastic SyndromesRemission InductionLung TransplantationLeukemia, MyeloidHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensAcute DiseaseRetrospective StudiesSurvival AnalysisColony-Forming Units AssayFanconi AnemiaLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHematologic DiseasesBone Marrow NeoplasmsT-LymphocytesOrgan TransplantationSevere Combined ImmunodeficiencyChimeraFollow-Up StudiesSurvival RateLeukocyte CountActuarial AnalysisGranulocyte Colony-Stimulating FactorLymphocyte TransfusionHemoglobinuria, ParoxysmalCord Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineGraft vs Tumor EffectCell TransplantationDisease-Free SurvivalPancreas TransplantationCytomegalovirus InfectionsGraft vs Leukemia EffectCell DifferentiationBone RemodelingIslets of Langerhans TransplantationCytarabinePeripheral Blood Stem Cell TransplantationBlood TransfusionGranulocytesFatal OutcomeSpleenBlood Cell CountMelphalanTransplantationLiving DonorsAnemia, RefractoryFlow Cytometry